Mesoderm is one of the three primary germ layers formed during embryonic development, along with ectoderm and endoderm. It arises during gastrulation, a crucial phase in early embryogenesis, when the blastula transforms into a trilaminar structure. Mesoderm occupies the middle layer, situated between the outer ectoderm and inner endoderm. From the mesoderm, various tissues and organs of the body develop, including the skeletal system, muscular system, cardiovascular system, kidneys, and reproductive organs. The mesoderm gives rise to mesenchymal cells, which have the capacity to differentiate into different cell types, contributing to the diversity of tissues and organs. The intricate process of mesodermal differentiation and migration is tightly regulated by signaling molecules and transcription factors. Aberrations in mesodermal development can lead to congenital anomalies and disorders affecting multiple organ systems. Understanding the molecular and cellular events during mesoderm formation is pivotal for elucidating embryonic development and has implications for regenerative medicine and understanding disease origins. Ongoing research continues to uncover the complexities of mesoderm specification and differentiation, advancing our knowledge of early embryonic patterning and providing insights into potential therapeutic strategies for developmental disorders.
Title : AI-integrated high-throughput tissue-chip for space-based biomanufacturing applications
Kunal Mitra, Florida Tech, United States
Title : Will be updated soon...
Vasiliki E Kalodimou, European University-Cyprus Ltd, Cyprus
Title : Will be updated soon...
Nagy Habib, Imperial College London, United Kingdom
Title : Will be updated soon...
Alexander Seifalian, Nanotechnology & Regenerative Medicine Commercialisation Centre, United Kingdom
Title : Advanced 3D tissue models: Pioneering tools for investigating health and disease
Lucie Bacakova, Institute of Physiology of the Czech Academy of Sciences, Czech Republic
Title : Developing iPSC-derived 3D Outer Blood-Retinal Barrier Disease Models of Choroideremia for Gene Therapy Evaluation
Aradhana Kasimsetty, National Center for Advancing Translational Sciences (NCATS), National Institutes of Health (NIH), United States